fura-2 has been researched along with Anesthesia Related Hyperthermia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pollock, N; Roesl, C; Sato, K; Schiemann, A; Stowell, KM | 1 |
| Koenig, F; Olthoff, D; Rueffert, H; Wehner, M | 1 |
| Kress, HG; Ludwig-Papst, C; Weigl, LG | 1 |
| Dietze, B; Eichinger, HM; Henke, J; Lehmann-Horn, F; Melzer, W | 1 |
| Katsuoka, M; Ohnishi, ST | 1 |
| Foder, B; Ording, H; Scharff, O | 1 |
| Iaizzo, PA; Klein, W; Lehmann-Horn, F | 1 |
1 trial(s) available for fura-2 and Anesthesia Related Hyperthermia
| Article | Year |
|---|---|
Cytosolic free calcium concentrations in lymphocytes from malignant hyperthermia susceptible patients.
Topics: Adult; Aged; Benzofurans; Calcium; Child; Cytosol; Disease Susceptibility; Female; Fura-2; Halothane; Humans; Lymphocytes; Male; Malignant Hyperthermia; Middle Aged | 1990 |
6 other study(ies) available for fura-2 and Anesthesia Related Hyperthermia
| Article | Year |
|---|---|
Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
Topics: Blotting, Western; Caffeine; Calcium; Cells, Cultured; Central Nervous System Stimulants; Cresols; Disease Susceptibility; Female; Fluorescent Antibody Technique; Fura-2; HEK293 Cells; Humans; Male; Malignant Hyperthermia; Muscle Fibers, Skeletal; Muscle, Skeletal; Mutation; Pedigree; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum | 2014 |
Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model.
Topics: Adolescent; Adult; Aged; Anesthetics; Biopsy; Caffeine; Calcium; Cells, Cultured; Central Nervous System Stimulants; Child; Child, Preschool; Cresols; Dose-Response Relationship, Drug; Exons; Family Health; Fungicides, Industrial; Fura-2; Halothane; Humans; In Vitro Techniques; Male; Malignant Hyperthermia; Middle Aged; Molecular Biology; Muscle Contraction; Muscle Fibers, Skeletal; Muscle, Skeletal; Mutation; Ryanodine Receptor Calcium Release Channel | 2004 |
4-chloro-m-cresol cannot detect malignant hyperthermia equivocal cells in an alternative minimally invasive diagnostic test of malignant hyperthermia susceptibility.
Topics: Caffeine; Calcium; Calibration; Cells, Cultured; Central Nervous System Stimulants; Cresols; DNA Mutational Analysis; DNA, Complementary; Fluorescent Dyes; Fura-2; Humans; Malignant Hyperthermia; Microtubules; Muscle Contraction; Muscle, Smooth, Vascular; RNA, Messenger; Ryanodine Receptor Calcium Release Channel | 2004 |
Malignant hyperthermia mutation Arg615Cys in the porcine ryanodine receptor alters voltage dependence of Ca2+ release.
Topics: Amino Acid Substitution; Animals; Calcium; Calcium Channels, L-Type; Chelating Agents; Egtazic Acid; Fura-2; Homozygote; In Vitro Techniques; Malignant Hyperthermia; Membrane Potentials; Muscle, Skeletal; Mutation; Patch-Clamp Techniques; Reaction Time; Ryanodine Receptor Calcium Release Channel; Swine | 2000 |
Why does halothane relax cardiac muscle but contract malignant hyperthermic skeletal muscle?
Topics: Animals; Caffeine; Calcium; Depression, Chemical; Fura-2; Halothane; In Vitro Techniques; Male; Malignant Hyperthermia; Muscle Contraction; Muscles; Myocardial Contraction; Myocardium; Perfusion; Rats; Rats, Inbred Strains; Sarcoplasmic Reticulum; Swine | 1991 |
Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs.
Topics: Animals; Benzofurans; Caffeine; Calcium; Disease Susceptibility; Fura-2; Halothane; Malignant Hyperthermia; Muscle Contraction; Muscles; Physical Exertion; Swine | 1988 |